Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Operating Margin (2018 - 2025)

Dna X's Operating Margin history spans 8 years, with the latest figure at 24.55% for Q3 2025.

  • Quarterly results put Operating Margin at 24.55% for Q3 2025, down 873.0% from a year ago — trailing twelve months through Dec 2025 was 12.25% (down 755.0% YoY), and the annual figure for FY2024 was 5.32%, down 587.0%.
  • Operating Margin for Q3 2025 was 24.55% at Dna X, up from 60.16% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 37.25% in Q4 2024 to a low of 74.23% in Q3 2021.
  • The 5-year median for Operating Margin is 16.03% (2024), against an average of 27.0%.
  • The sharpest move saw Operating Margin soared 6931bps in 2022, then tumbled -5897bps in 2024.
  • Year by year, Operating Margin stood at 73.71% in 2021, then soared by 94bps to 4.39% in 2022, then tumbled by -113bps to 9.34% in 2023, then soared by 499bps to 37.25% in 2024, then crashed by -166bps to 24.55% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods came in at 24.55%, 60.16%, and 3.86% for Q3 2025, Q2 2025, and Q1 2025 respectively.